Idiopathic Inflammatory Myositis
·MeSH: Myositis
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| daxdilimab | AMGEN INC (AMGN) |
Frequently asked questions
How many drugs are in development for Idiopathic Inflammatory Myositis?
BioSniper tracks 1 drug in development for Idiopathic Inflammatory Myositis across 1 company.
How many clinical trials target Idiopathic Inflammatory Myositis?
There are 1 clinical trial targeting Idiopathic Inflammatory Myositis tracked by BioSniper.
Deep-dive into Idiopathic Inflammatory Myositis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis